Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of PXR activation by rifampicin on HDL cholesterol, glucose metabolism, and blood pressure in healthy volunteers
2016-003347-10Phase 4Terminated
- Sponsor
- Oulu University Hospital
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing rifampicin with placebo (2 arms). Primary endpoint: Percent change of HDL2 fraction between baseline and week 4. Started Dec 2016; status: terminated.
02
Drugs
rifampicin
Beyond the preview
Go deeper on 2016-003347-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003347-10.